Evidence map›Paper›PMID 36193893›Full record

ArticleeLife2022

Hepatic inactivation of murine

Vi T Tang, Joseph McCormick, Bolin Xu, Yawei Wang, Huan Fang, Xiao Wang, David Siemieniak, Rami Khoriaty, Brian T Emmer, Xiao-Wei Chen and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Genetics of hemostasis: from bedside to bench and back again.The Journal of clinical investigation · 2024
    Article
  10. Review
  11. Functional overlap between the mammalianProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Functional overlap between the mammalianbioRxiv : the preprint server for biology · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Vi T TangDepartment of Molecular and Integrative Physiology, University of Michigan-Ann Arbor, Ann Arbor, United States.ORCID 0000-0001-6079-9756
Joseph McCormickLife Sciences Institute, University of Michigan-Ann Arbor, Ann Arbor, United States.
Bolin XuCollege of Future Technology, Peking University, Beijing, China.
Yawei WangCenter for Life Sciences, Peking University, Beijing, China.
Huan FangCollege of Future Technology, Peking University, Beijing, China.
Xiao WangCollege of Future Technology, Peking University, Beijing, China.
David SiemieniakLife Sciences Institute, University of Michigan-Ann Arbor, Ann Arbor, United States.
Rami KhoriatyDepartment of Internal Medicine, University of Michigan-Ann Arbor, Ann Arbor, United States.
Brian T EmmerDepartment of Internal Medicine, University of Michigan-Ann Arbor, Ann Arbor, United States.ORCID 0000-0001-7365-1021
Xiao-Wei ChenState Key Laboratory of Membrane Biology, Peking University, Beijing, China.ORCID 0000-0003-4564-5120
David GinsburgLife Sciences Institute, University of Michigan-Ann Arbor, Ann Arbor, United States.ORCID 0000-0002-6436-8942
University of Michigan · USKing University · USHoward Hughes Medical Institute · USPeking University · CN

Funding

The molecular pathophysiology of the congenital dyserythropoietic anemiasR01HL148333 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Rami Khoriaty · 2019 to 2026
$4.6M
The Molecular Genetics of HemostasisR35HL135793 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GINSBURG, DAVID · 2017 to 2023
$4.1M
The regulation of thrombopoietin levelsR01HL157062 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KHORIATY, RAMI · 2021 to 2024
$2.1M
Cholesterol regulation by the cargo receptor SURF4K08HL148552 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI EMMER, BRIAN T · 2019 to 2023
$788k
NHLBI NIH HHS K08 HL148552NHLBI NIH HHS R01 HL148333NHLBI NIH HHS R01 HL157062NHLBI NIH HHS R35 HL135793
6 · The paper itself

Abstract

PCSK9 negatively regulates low-density lipoprotein receptor (LDLR) abundance on the cell surface, leading to decreased hepatic clearance of LDL particles and increased levels of plasma cholesterol. We previously identified SURF4 as a cargo receptor that facilitates PCSK9 secretion in HEK293T cells (Emmer et al., 2018). Here, we generated hepatic SURF4-deficient mice (

Indexed as

Proprotein Convertase 9Receptors, LDLAnimalsApolipoproteins BCholesterolHEK293 CellsHumansLipoproteinsLipoproteins, LDLLiverMembrane ProteinsMiceMice, Inbred C57BLRNA, Small InterferingTriglyceridesApolipoproteins BCholesterolLipoproteinsLipoproteins, LDLMembrane ProteinsPCSK9 protein, humanProprotein Convertase 9Receptors, LDLRNA, Small InterferingSURF4 protein, humanSurf4 protein, mouseTriglyceridesAPOBcell biologycholesterolmousePCSK9secretionSURF4

Identifiers

PMID36193893
PMCPMC9581532
OpenAlexW4301392339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.